Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Commerce Township › NPI 1922310200
Hospital

VHS Huron Valley-Sinai Hospital INC

VHS Huron Valley-Sinai Hospital INC was paid $9.34M by Medicaid between Jan 2018 and Dec 2024, across 157 billing codes. Its largest line is 99284, emergency room visit (serious) — 22% of everything it billed.

33Billing provider infoVHS HURON VALLEY-SINAI HOSPITAL INC
COMMERCE TOWNSHIP, MI 48382
33aNPI1922310200assigned 07/02/2010
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.34M
24GClaims272,202
24DCodes billed157
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#65 of 86
Median peer was paid$21.55M
This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201838,748$1.29M
201938,021$1.25M
202032,690$992K
202139,492$1.37M
202241,507$1.42M
202345,289$1.51M
2024incomplete36,455$1.51M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 22% 10,354 9,844 $2.02M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 20% 6,141 5,797 $1.90M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 13,245 12,745 $1.54M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.8% 6,964 6,461 $542K
G0378 Hospital observation service, per hour 4.9% 1,340 1,272 $456K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.2% 6,589 5,841 $393K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.4% 1,828 1,791 $225K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.3% 2,434 1,499 $217K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.1% 2,599 2,517 $196K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1.8% 3,890 3,567 $165K
96375 Therapeutic injection; each additional sequential IV push 1.7% 5,774 4,834 $160K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 1.3% 826 795 $123K
145 more codes
71045 Radiologic examination, chest; single view 1.2% 3,675 $113K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 493 $106K
77067 Screening mammography, bilateral, including computer-aided detection 1.1% 2,078 $100K
71046 Radiologic examination, chest; 2 views 1.0% 3,216 $95K
70450 Computed tomography, head or brain; without contrast material <1% 1,469 $84K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,426 $82K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,424 $76K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 849 $71K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 697 $66K
86900 <1% 2,161 $64K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,598 $58K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 469 $58K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 803 $37K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 801 $35K
76830 Ultrasound, transvaginal <1% 632 $33K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 234 $30K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,208 $29K
59025 Fetal non-stress test <1% 324 $28K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 145 $19K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 334 $18K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 262 $18K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 677 $15K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 614 $13K
96361 Intravenous infusion, hydration; each additional hour <1% 369 $13K
93017 <1% 496 $12K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 129 $12K
77063 Screening digital breast tomosynthesis, bilateral <1% 618 $8K
83735 <1% 8,925 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 959 $7K
80053 Comprehensive metabolic panel <1% 4,714 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,411 $7K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 8,016 $6K
93971 <1% 129 $6K
80048 Basic metabolic panel (calcium, ionized) <1% 10,320 $6K
76642 <1% 160 $6K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 5,322 $5K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,265 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,219 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,395 $4K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 23 $4K
81003 <1% 2,995 $3K
76770 <1% 49 $3K
82962 <1% 1,078 $3K
0012A <1% 63 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,243 $2K
0011A <1% 57 $2K
73630 <1% 418 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 897 $2K
Q3014 Telehealth originating site facility fee <1% 107 $2K
85027 <1% 9,019 $1K
73130 <1% 225 $1K
81025 <1% 2,736 $1K
76536 <1% 26 $1K
76801 <1% 26 $1K
81001 <1% 3,800 $1K
82728 <1% 289 $1K
84484 <1% 3,488 $1K
84703 <1% 2,354 $999.24
73030 <1% 133 $972.48
86850 <1% 2,142 $858.12
73610 <1% 245 $788.98
J2704 Injection, propofol, 10 mg <1% 4,869 $739.25
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,230 $707.47
36415 Collection of venous blood by venipuncture <1% 1,456 $625.21
J0690 Injection, cefazolin sodium, 500 mg <1% 2,465 $592.42
83550 <1% 201 $522.69
71250 <1% 12 $486.66
83690 <1% 3,361 $468.05
72125 Computed tomography, cervical spine; without contrast material <1% 30 $431.16
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 24 $424.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 24 $424.00
85610 <1% 2,367 $403.08
83540 <1% 203 $391.85
87086 Culture, bacterial; quantitative colony count, urine <1% 273 $363.37
72100 <1% 25 $330.21
73564 <1% 57 $314.37
86901 <1% 2,144 $303.23
82565 <1% 879 $296.05
85730 <1% 2,236 $282.65
84460 <1% 1,894 $278.41
84450 <1% 1,899 $273.45
82607 <1% 69 $253.43
80051 <1% 561 $246.45
87631 <1% 684 $224.08
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 191 $198.26
84443 Thyroid stimulating hormone (TSH) <1% 68 $192.61
J1170 Injection, hydromorphone, up to 4 mg <1% 3,026 $190.46
J7050 Infusion, normal saline solution, 250 cc <1% 3,092 $180.96
73110 <1% 38 $164.59
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,961 $164.33
J3475 Injection, magnesium sulfate, per 500 mg <1% 488 $161.38
82247 <1% 1,230 $141.64
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,895 $118.93
90674 <1% 17 $117.86
A9270 Non-covered item or service <1% 18,740 $114.84
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,957 $114.19
82248 <1% 1,202 $108.60
74018 <1% 12 $97.62
83880 <1% 350 $94.60
84702 <1% 223 $94.11
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 496 $92.84
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 299 $74.57
82746 <1% 13 $69.82
J1644 Injection, heparin sodium, per 1000 units <1% 973 $68.35
72170 <1% 13 $60.83
84520 <1% 369 $55.10
G0008 Administration of influenza virus vaccine <1% 16 $53.68
73590 <1% 13 $48.57
84075 <1% 909 $36.99
82947 <1% 25 $36.15
84100 <1% 354 $27.78
J0780 Injection, prochlorperazine, up to 10 mg <1% 564 $27.68
90715 <1% 877 $25.95
85379 <1% 241 $24.67
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 72 $23.64
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,768 $21.18
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 578 $19.04
J2060 Injection, lorazepam, 2 mg <1% 187 $15.31
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 282 $12.02
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 384 $11.93
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 727 $8.47
J3370 Injection, vancomycin hcl, 500 mg <1% 136 $6.68
83605 <1% 115 $6.46
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,340 $2.61
J1630 Injection, haloperidol, up to 5 mg <1% 13 $1.04
96376 0% 1,306 $0.00
87807 0% 108 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 879 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 775 $0.00
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 0% 66 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 114 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 196 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 15 $0.00
94760 0% 14 $0.00
12001 0% 14 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 15 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 451 $0.00
S0028 Injection, famotidine, 20 mg 0% 218 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 0% 16 $0.00
A9576 Injection, gadoteridol, (prohance multipack), per ml 0% 120 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 112 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 13 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 72 $0.00
C1729 Catheter, drainage 0% 33 $0.00
64447 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBABB, DANIEL (CFO)
Same official

Other billing entities under BABB, DANIEL

Full network →
ProviderLocationPaid
VHS Rehabilitation Institute of Michigan INCDetroit, MI$23.98M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.